Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Public Health and Surveillance

Date Submitted: Nov 12, 2020
Date Accepted: Dec 3, 2020
Date Submitted to PubMed: Dec 16, 2020

The final, peer-reviewed published version of this preprint can be found here:

Drivers of Acceptance of COVID-19 Proximity Tracing Apps in Switzerland: Panel Survey Analysis

von Wyl V, Höglinger M, Sieber C, Kaufmann M, Moser A, Serra-Burriel M, Ballouz T, Menges D, Frei A, Puhan MA

Drivers of Acceptance of COVID-19 Proximity Tracing Apps in Switzerland: Panel Survey Analysis

JMIR Public Health Surveill 2021;7(1):e25701

DOI: 10.2196/25701

PMID: 33326411

PMCID: 7790736

Drivers of acceptance of COVID-19 proximity tracing apps in Switzerland: a panel survey analysis

  • Viktor von Wyl; 
  • Marc Höglinger; 
  • Chloé Sieber; 
  • Marco Kaufmann; 
  • André Moser; 
  • Miquel Serra-Burriel; 
  • Tala Ballouz; 
  • Dominik Menges; 
  • Anja Frei; 
  • Milo Alan Puhan

ABSTRACT

Background:

Digital proximity tracing (DPT) apps have been released to mitigate SARS-CoV-2 transmission. But it remains unclear how their acceptance and uptake can be improved.

Objective:

The aim of this study was to investigate SwissCovid app coverage and reasons for not using the app in Switzerland during a time of increasing SARS-CoV-2 incidence.

Methods:

By use of data collected between 28.09.2020 to 08.10.2020 for a nationwide online panel survey (Covid-19 Social Monitor, n=1’511 participants), socio-demographic and behavioral factors associated with app usage were examined using multivariable logistic regression. Reasons for app non-use were analyzed descriptively.

Results:

Overall, 46.5% of participants reported to use the SwissCovid app (up from 43.9% in a study wave conducted in July 2020). A higher monthly household income (e.g. OR 1.92 [1.40-2.64] for an income >CHF 10’000 vs. an income ≤ CHF 6’000), more frequent internet use (e.g., daily (reference) vs. less than weekly OR 0.37 [0.16-0.85]), better adherence to mask wearing recommendations (e.g., always or most of time (reference) vs. rarely or never OR 0.28 [0.15-0.52]), and being a non-smoker (OR 1.32 [1.01-1.71]) were associated with an increased likelihood for app uptake. Citizenship status (e.g., non-Swiss citizenship 0.61 [0.43-0.87] vs. Swiss citizenship only), and language region (French 0.61 [0.46-0.80], vs. Swiss German) were associated with a lower app uptake probability. In a randomly selected subsample (n=711) with more detailed information, higher levels of trust in government and health authorities was additionally associated with a higher app uptake probability (e.g., OR 3.13 [1.58-6.22] for high vs. low trust (reference)). The most frequent reasons for app non-use was lack of perceived benefit of the app (36.8%), 22.8% reported to have no compatible phone, and 22.4% had privacy concerns.

Conclusions:

Removing technical hurdles and communicating the benefits of DPT-apps are crucial to promote further uptake, compliance, and ultimately to enhance effectiveness of DPT-apps for pandemic mitigation.


 Citation

Please cite as:

von Wyl V, Höglinger M, Sieber C, Kaufmann M, Moser A, Serra-Burriel M, Ballouz T, Menges D, Frei A, Puhan MA

Drivers of Acceptance of COVID-19 Proximity Tracing Apps in Switzerland: Panel Survey Analysis

JMIR Public Health Surveill 2021;7(1):e25701

DOI: 10.2196/25701

PMID: 33326411

PMCID: 7790736

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.